In this work, with the perspective that co-targeting TSPO and MDM2/p53 with one molecule could maximize the anti-tumor efficacy, dual binders were rationally designed, synthesized and biologically characterized in human GBM cells. This evidence concerns the gene TP53 and neoplasm.